CO6160333A2 - Bacterinas tratadas con calor y vacunas de emulsion preparadas a partir de estas bacterinas tratadas con calor - Google Patents
Bacterinas tratadas con calor y vacunas de emulsion preparadas a partir de estas bacterinas tratadas con calorInfo
- Publication number
- CO6160333A2 CO6160333A2 CO09024344A CO09024344A CO6160333A2 CO 6160333 A2 CO6160333 A2 CO 6160333A2 CO 09024344 A CO09024344 A CO 09024344A CO 09024344 A CO09024344 A CO 09024344A CO 6160333 A2 CO6160333 A2 CO 6160333A2
- Authority
- CO
- Colombia
- Prior art keywords
- bacterin
- heat
- heat treated
- lipase activity
- leptospira
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/0225—Spirochetes, e.g. Treponema, Leptospira, Borrelia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Virology (AREA)
- Dispersion Chemistry (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- Enzymes And Modification Thereof (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
1.- Una bacterina tratada con calor, que comprende una suspensión de bacterias muertas que tienen una actividad lipasa de 50% o menos con respecto a la actividad lipasa de la bacterina antes del tratamiento con calor. 2.- Una bacterina tratada con calor de acuerdo con la reivindicación 1, donde e! tratamiento con calor comprende calentar una bacterina que tiene actividad lipasa a una temperatura de aproximadamente 35 a aproximadamente 80°C durante un periodo de aproximadamente 20 minutos a aproximadamente 24 horas. 3.- Una bacterina tratada con calor de acuerdo con la reivindicación 1, donde el tratamiento con calor comprende calentar una bacterina que tiene actividad lipasa a una temperatura de aproximadamente 60 a aproximadamente 70°C durante un periodo de aproximadamente 5 a aproximadamente 10 horas. 4.- Una bacterina tratada con calor de acuerdo con la reivindicación 1, donde el tratamiento con calor comprende calentar una bacterina que tiene actividad lipasa a una temperatura de aproximadamente 65 a aproximadamente 70°C durante un periodo de aproximadamente 9 a aproximadamente 8 horas. 5.- Una bacterina tratada con calor que comprende una suspensión de bacterias muertas de acuerdo con la reivindicación 1, donde el tratamiento con calor comprende: calentar una bacterina que tiene actividad lipasa a una temperatura de aproximadamente 65 a aproximadamente 70°C durante aproximadamente 1 hora. 6.- Una bacterina tratada con calor que comprende una suspensión de bacterias muertas de acuerdo con la reivindicación 1, donde el tratamiento con calor comprende: calentar una bacterina que tiene actividad lipasa a una temperatura de aproximadamente 55 a aproximadamente 65°C durante un periodo de aproximadamente 5 a aproximadamente 8 horas. 7.- Una bacterina tratada con calor que comprende una suspensión de bacterias muertas de acuerdo con la reivindicación 2, donde las bacterias muertas son de una a cinco especies de Leptospira seleccionadas entre el grupo compuesto por Leptospira canicola, Leptospira grippotyposa, Leptospira hardjo, Leptospira icterohaemorrhagiae y Leptospira pomona.8.- Una vacuna que comprende una emulsión y una bacterina tratada con calor de acuerdo con la reivindicación 2. 9.- Una vacuna de acuerdo con la reivindicación 8, que comprende además virus vivos.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US84366506P | 2006-09-11 | 2006-09-11 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CO6160333A2 true CO6160333A2 (es) | 2010-05-20 |
Family
ID=39110574
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CO09024344A CO6160333A2 (es) | 2006-09-11 | 2009-03-10 | Bacterinas tratadas con calor y vacunas de emulsion preparadas a partir de estas bacterinas tratadas con calor |
Country Status (27)
| Country | Link |
|---|---|
| US (1) | US8491915B2 (es) |
| EP (2) | EP2066340B1 (es) |
| JP (2) | JP5550341B2 (es) |
| KR (1) | KR101238486B1 (es) |
| CN (1) | CN101516393B (es) |
| AR (1) | AR062758A1 (es) |
| AU (1) | AU2007297287B2 (es) |
| BR (1) | BRPI0716548B1 (es) |
| CA (1) | CA2663166C (es) |
| CL (1) | CL2007002621A1 (es) |
| CO (1) | CO6160333A2 (es) |
| DK (2) | DK2066340T3 (es) |
| ES (2) | ES2535977T3 (es) |
| HK (1) | HK1130202A1 (es) |
| ME (1) | ME00598B (es) |
| MX (1) | MX2009001849A (es) |
| NO (1) | NO339147B1 (es) |
| NZ (2) | NZ595748A (es) |
| PL (2) | PL2377550T3 (es) |
| PT (1) | PT2066340E (es) |
| RS (1) | RS54981B1 (es) |
| RU (2) | RU2425692C2 (es) |
| SI (1) | SI2066340T1 (es) |
| TW (1) | TWI361077B (es) |
| UA (1) | UA98115C2 (es) |
| WO (1) | WO2008032158A2 (es) |
| ZA (1) | ZA200902493B (es) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106562927A (zh) * | 2007-12-21 | 2017-04-19 | 硕腾服务有限责任公司 | 经热处理的菌苗，及由这些经热处理的菌苗制备的乳剂疫苗 |
| EP2717055A1 (en) * | 2012-10-04 | 2014-04-09 | Institut Pasteur | Use of Leptospira fainei serovar Hurstbridge bacteria for diagnosing leptospirosis |
| WO2021242279A1 (en) * | 2020-05-26 | 2021-12-02 | Cyrus 21St Century Entrpreneurship Llc | Hakim pour cina's gand zoda-e |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3721169A1 (de) * | 1986-06-30 | 1988-01-14 | Lion Corp | Orale zubereitung |
| US5084269A (en) | 1986-11-06 | 1992-01-28 | Kullenberg Fred W | Adjuvant for dose treatment with antigens |
| US6248329B1 (en) * | 1998-06-01 | 2001-06-19 | Ramaswamy Chandrashekar | Parasitic helminth cuticlin nucleic acid molecules and uses thereof |
| AU2001234616A1 (en) | 2000-01-31 | 2001-08-07 | Vic Jira | Vaccine composition, process and methods |
| US20030147914A1 (en) | 2001-07-02 | 2003-08-07 | Pfizer Inc. | Mycoplasma bovis vaccine and methods of reducing pneumonia in animals |
| BR0313806A (pt) | 2002-08-26 | 2005-07-05 | Pfizer Prod Inc | Vacinas para infecções nos sistemas respiratório e reprodutor em gado |
| AU2003270779A1 (en) | 2002-09-20 | 2004-04-08 | The United States Of America As Represented By The Secretary Of Agriculture | Vaccine compositions and adjuvant |
| AU2002951692A0 (en) | 2002-09-23 | 2002-10-17 | Vital Biotech (Hong Kong) Limited | Improvements in or relating to vaccines |
| EP1592444B1 (en) * | 2003-01-29 | 2008-05-14 | Pfizer Products Inc. | Canine vaccines against bordetella bronchiseptica |
| PL1613346T3 (pl) * | 2003-04-04 | 2013-03-29 | Zoetis Services Llc | Poddane mikrofluidyzacji emulsje typu olej w wodzie i kompozycje szczepionek |
-
2007
- 2007-08-30 RU RU2009108004/10A patent/RU2425692C2/ru active
- 2007-08-30 PL PL11173797T patent/PL2377550T3/pl unknown
- 2007-08-30 EP EP07804880.8A patent/EP2066340B1/en active Active
- 2007-08-30 WO PCT/IB2007/002553 patent/WO2008032158A2/en active Application Filing
- 2007-08-30 ES ES11173797.9T patent/ES2535977T3/es active Active
- 2007-08-30 EP EP11173797.9A patent/EP2377550B1/en active Active
- 2007-08-30 PL PL07804880T patent/PL2066340T3/pl unknown
- 2007-08-30 JP JP2009527907A patent/JP5550341B2/ja active Active
- 2007-08-30 NZ NZ595748A patent/NZ595748A/xx unknown
- 2007-08-30 AU AU2007297287A patent/AU2007297287B2/en active Active
- 2007-08-30 RS RS20090088A patent/RS54981B1/sr unknown
- 2007-08-30 SI SI200731337T patent/SI2066340T1/sl unknown
- 2007-08-30 UA UAA200902099A patent/UA98115C2/ru unknown
- 2007-08-30 BR BRPI0716548-0A patent/BRPI0716548B1/pt active IP Right Grant
- 2007-08-30 MX MX2009001849A patent/MX2009001849A/es active IP Right Grant
- 2007-08-30 CN CN200780033767.2A patent/CN101516393B/zh active Active
- 2007-08-30 KR KR1020097004968A patent/KR101238486B1/ko active IP Right Grant
- 2007-08-30 DK DK07804880.8T patent/DK2066340T3/da active
- 2007-08-30 ES ES07804880T patent/ES2432392T3/es active Active
- 2007-08-30 NZ NZ574896A patent/NZ574896A/en unknown
- 2007-08-30 CA CA2663166A patent/CA2663166C/en active Active
- 2007-08-30 PT PT78048808T patent/PT2066340E/pt unknown
- 2007-08-30 ME MEP-2009-75A patent/ME00598B/me unknown
- 2007-08-30 DK DK11173797T patent/DK2377550T3/en active
- 2007-09-07 US US11/851,951 patent/US8491915B2/en active Active
- 2007-09-10 CL CL200702621A patent/CL2007002621A1/es unknown
- 2007-09-10 TW TW096133683A patent/TWI361077B/zh active
- 2007-09-11 AR ARP070104028A patent/AR062758A1/es not_active Application Discontinuation
-
2009
- 2009-02-16 NO NO20090745A patent/NO339147B1/no unknown
- 2009-03-10 CO CO09024344A patent/CO6160333A2/es unknown
- 2009-04-09 ZA ZA200902493A patent/ZA200902493B/xx unknown
- 2009-10-08 HK HK09109330.1A patent/HK1130202A1/xx unknown
-
2011
- 2011-04-20 RU RU2011115400/10A patent/RU2569457C2/ru active
-
2014
- 2014-01-14 JP JP2014004122A patent/JP5643906B2/ja active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2015109724A (ru) | Жидкие стабильные вирусные вакцины | |
| BRPI0607551A2 (pt) | vacinas de combinação de helicobacter e circovìrus porcino e métodos de uso | |
| IN2014DN08830A (es) | ||
| CO6260102A2 (es) | Cepas de mycoplasma gallisepticum atenuadas | |
| AR075484A1 (es) | Pestivirus quimericos | |
| AR043892A1 (es) | Metodos para prevenir enfermedades reproductivas en el ganado vacuno | |
| CO6160333A2 (es) | Bacterinas tratadas con calor y vacunas de emulsion preparadas a partir de estas bacterinas tratadas con calor | |
| BR112014001409A2 (pt) | métodos e composições para vacinação contra staphylococcus aureus | |
| DE602004028029D1 (en) | Rwendung | |
| WO2009077577A3 (en) | Vaccine antigens from piscirickettsia salmonis | |
| RU2015109124A (ru) | Иммуногенная композиция из убитой бактерии лептоспиры | |
| CY1113061T1 (el) | Ανοσογονες συνθεσεις για θεραπεια και προληψη ζωικων μολυνσεων | |
| WO2008121487A3 (en) | Live attenuated virus vaccines for la crosse virus and other bunyaviridae | |
| RU2013135887A (ru) | Композиции для комплекса респираторных заболеваний собак | |
| US20220213448A1 (en) | Viral vaccines and methods of forming the same | |
| US11286464B2 (en) | Viral vaccines and methods of forming the same | |
| RU2013126074A (ru) | Вакцина против чумы, аденовирусных инфекций, парвовирусного и коронавирусного энтеритов, лептоспироза и бешенства собак | |
| Arshad et al. | Experimental Trials of Foot-and-Mouth Disease Vaccines with Different Vegetable Oil Adjuvants in Goats under Field Conditions. | |
| Desmettre | Veterinary vaccines in the development of vaccination and vaccinology | |
| RU2019120045A (ru) | Вакцина для свиней | |
| Ukhovskyi | Study on immunogenic characteristics of experimental series of polyvalent vaccine against leptospirosis of animals" variant BOVIS" in laboratory conditions | |
| AR084225A1 (es) | Composiciones y metodos para vacunar ganado vacuno | |
| Guimarães et al. | Yellow fever vaccine, recombinant envelope protein (rYFE), plant derived, for active immunization: Pre-clinical studies in mice and monkey models | |
| PH22018000417Y1 (en) | Monovalent losbanos vaccine against locally prevalent leptospira serovar in the philippines | |
| PH22018000416U1 (en) | Bivalent manilae and losbanos vaccine against locally prevalent leptospira serovars in the philippines |